These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10619651)
21. [Therapeutic potential of thyreoliberin (TRH) and its analogues as antiepileptic and neuroprotective drugs]. Jantas D Przegl Lek; 2010; 67(11):1179-85. PubMed ID: 21442973 [TBL] [Abstract][Full Text] [Related]
22. Putative neurotransmitter abnormalities in infantile spasms: cerebrospinal fluid neurochemistry and drug effects. Pranzatelli MR J Child Neurol; 1994 Apr; 9(2):119-29. PubMed ID: 7911815 [TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid gamma-aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment. Löscher W; Siemes H Epilepsia; 1985; 26(4):314-9. PubMed ID: 4006890 [TBL] [Abstract][Full Text] [Related]
25. [Elimination of metabolites of tryptophan in neurologic diseases of the child. 2. Action exercised by ACTH and pyridoxin on urinary elimination of kynurenine derivatives]. Fois A; Lecchini L Riv Clin Pediatr; 1965; 75(1):11-4. PubMed ID: 4285746 [No Abstract] [Full Text] [Related]
26. Stimulant effect of thyrotropin-releasing hormone and its analog, RGH 2202, on the diaphragm respiratory activity, and their antagonism with morphine: possible involvement of the N-methyl-D-aspartate receptors. Kharkevich DA; Chizh BA; Kasparov SA Brain Res; 1991 Jun; 551(1-2):110-5. PubMed ID: 1833029 [TBL] [Abstract][Full Text] [Related]
27. Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. Medana IM; Day NP; Salahifar-Sabet H; Stocker R; Smythe G; Bwanaisa L; Njobvu A; Kayira K; Turner GD; Taylor TE; Hunt NH J Infect Dis; 2003 Sep; 188(6):844-9. PubMed ID: 12964115 [TBL] [Abstract][Full Text] [Related]
28. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Bay-Richter C; Linderholm KR; Lim CK; Samuelsson M; Träskman-Bendz L; Guillemin GJ; Erhardt S; Brundin L Brain Behav Immun; 2015 Jan; 43():110-7. PubMed ID: 25124710 [TBL] [Abstract][Full Text] [Related]
29. Prolonged seizure suppression by a single implantable polymeric-TRH microdisk preparation. Kubek MJ; Liang D; Byrd KE; Domb AJ Brain Res; 1998 Nov; 809(2):189-97. PubMed ID: 9853110 [TBL] [Abstract][Full Text] [Related]
30. Interaction between thyrotropin-releasing hormone (TRH) and NMDA-receptor-mediated responses in hypoglossal motoneurones. Rekling JC Brain Res; 1992 Apr; 578(1-2):289-96. PubMed ID: 1354998 [TBL] [Abstract][Full Text] [Related]
31. [Effectiveness of TRH analog in a case of early infantile epileptic encephalopathy]. Ishii M; Tamai K; Sugita K; Tanabe Y No To Hattatsu; 1990 Sep; 22(5):507-11. PubMed ID: 2121173 [TBL] [Abstract][Full Text] [Related]
32. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. Beal MF; Matson WR; Swartz KJ; Gamache PH; Bird ED J Neurochem; 1990 Oct; 55(4):1327-39. PubMed ID: 2144582 [TBL] [Abstract][Full Text] [Related]
33. Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. Young SN; Gauthier S; Anderson GM; Purdy WC J Neurol Neurosurg Psychiatry; 1980 May; 43(5):438-45. PubMed ID: 6158559 [TBL] [Abstract][Full Text] [Related]
34. TRH modulates glutamatergic synaptic inputs on CA1 neurons of the mouse hippocampus in a biphasic manner. Zarif H; Petit-Paitel A; Heurteaux C; Chabry J; Guyon A Neuropharmacology; 2016 Nov; 110(Pt A):69-81. PubMed ID: 27060411 [TBL] [Abstract][Full Text] [Related]
35. Transport of thyrotropin-releasing hormone from cerebrospinal fluid to hypophysial portal blood and the release of thyrotropin. Oliver C; Ben-Jonathan N; Mical RS; Porter JC Endocrinology; 1975 Nov; 97(5):1138-43. PubMed ID: 810342 [TBL] [Abstract][Full Text] [Related]
36. Thyrotropin-releasing hormone (TRH) and its beta-alanine analogue: potentiation of the anticonvulsant potency of phenobarbital in mice. Nemeroff CB; Prange AJ; Bissette G; Breese GR; Lipton MA Psychopharmacol Commun; 1975; 1(3):305-17. PubMed ID: 817374 [TBL] [Abstract][Full Text] [Related]
37. Monoamine metabolites in the cerebrospinal fluid in infantile spinal muscular atrophy. Takeuchi Y; Komatsu H; Matsuo S; Hirai K; Kawase S; Nishimura A; Sawada T Neuroreport; 1994 Apr; 5(8):898-900. PubMed ID: 8061291 [TBL] [Abstract][Full Text] [Related]
38. Thyrotropin-releasing hormone increases GABA release in rat hippocampus. Deng PY; Porter JE; Shin HS; Lei S J Physiol; 2006 Dec; 577(Pt 2):497-511. PubMed ID: 16990402 [TBL] [Abstract][Full Text] [Related]
39. TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats. Kinoshita K; Watanabe Y; Yamamura M; Matsuoka Y Eur J Pharmacol; 1998 Feb; 343(2-3):129-33. PubMed ID: 9570459 [TBL] [Abstract][Full Text] [Related]
40. Clinical studies of thyrotropin-releasing hormone tartrate (TRH-T) as a direct stimulant to the central nervous system. Ogashiwa M; Takeuchi K Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):145-51. PubMed ID: 36357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]